
Basilea presents new data on antifungals fosmanogepix, isavuconazole, and antibiotic ceftobiprole at IDWeek 2026
Basilea Pharmaceutica announced new clinical and activity data for its antifungal drugs fosmanogepix and isavuconazole, as well as the antibiotic ceftobiprole, to be presented at IDWeek 2026 in Washington D.C. Highlights include pediatric data from f...





